• 1. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 2. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 3. Fast synthesis of copper nanoclusters through the use of hydrogen peroxide additive and their application for the fluorescence detection of Hg2+ in water samples?
  Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248
• 4. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
• 5. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555

Research Briefing on 1-(2-bromo-3-chlorophenyl)ethan-1-one (CAS: 161957-60-4): Recent Advances and Applications

1-(2-bromo-3-chlorophenyl)ethan-1-one (CAS: 161957-60-4) is a halogenated aromatic ketone that has garnered significant attention in the field of chemical biology and pharmaceutical research. This compound serves as a key intermediate in the synthesis of various bioactive molecules, including potential drug candidates. Recent studies have explored its utility in medicinal chemistry, particularly in the development of novel therapeutic agents targeting infectious diseases, cancer, and neurological disorders. This briefing synthesizes the latest findings related to this compound, highlighting its chemical properties, synthetic applications, and biological activities.

Recent research has demonstrated the versatility of 1-(2-bromo-3-chlorophenyl)ethan-1-one as a building block in organic synthesis. A study published in the Journal of Medicinal Chemistry (2023) detailed its use in the synthesis of brominated and chlorinated derivatives with enhanced pharmacokinetic properties. The compound's unique halogen substitution pattern allows for selective functionalization, enabling the creation of libraries of analogs for structure-activity relationship (SAR) studies. These efforts have led to the identification of several lead compounds with promising antimicrobial and anticancer activities.

In the context of drug discovery, 1-(2-bromo-3-chlorophenyl)ethan-1-one has been employed in the development of kinase inhibitors. A 2024 study in Bioorganic & Medicinal Chemistry Letters reported its incorporation into a series of small-molecule inhibitors targeting the PI3K/AKT/mTOR pathway, which is implicated in various cancers. The researchers observed that derivatives of this compound exhibited potent inhibitory activity against cancer cell lines, with IC50 values in the nanomolar range. These findings underscore its potential as a scaffold for oncology-focused drug design.

Beyond its applications in medicinal chemistry, 1-(2-bromo-3-chlorophenyl)ethan-1-one has also been investigated for its role in agrochemical research. A recent publication in Pest Management Science (2024) highlighted its use as a precursor for the synthesis of novel pesticides. The study demonstrated that halogenated derivatives of this compound exhibited significant insecticidal activity against economically important pests, with low toxicity to non-target organisms. This dual utility in pharmaceuticals and agrochemicals further emphasizes its importance in chemical research.

In conclusion, 1-(2-bromo-3-chlorophenyl)ethan-1-one (CAS: 161957-60-4) continues to be a valuable compound in chemical biology and pharmaceutical research. Its versatility as a synthetic intermediate, combined with its potential biological activities, makes it a focal point for ongoing investigations. Future research directions may include optimizing its derivatives for clinical applications and exploring its mechanisms of action in greater detail. This briefing underscores the compound's relevance and the need for continued exploration of its therapeutic and industrial potential.

• 54826-14-1(3-Bromo-4-chloroacetophenone)
• 61601-45-4(9,10-Anthracenedione, 1,5-dibromo-2-chloro-)
• 89244-53-1(Ethanone, 1,1'-(2,5-dibromo-3,6-dichloro-1,4-phenylene)bis-)
• 835-09-6(Methanone, (2-bromo-5-chlorophenyl)phenyl-)
• 935-99-9(1-(2-bromo-5-chlorophenyl)ethan-1-one)
• 825-40-1(1-(2-bromo-4-chlorophenyl)ethan-1-one)
• 74073-40-8(2-Bromo-3-chlorobenzaldehyde)
• 99585-64-5(2-Bromo-4'-chlorobenzophenone)
• 3114-31-6(1-(4-bromo-3-chlorophenyl)ethan-1-one)
• 782-03-6(Methanone, (3-bromo-4-chlorophenyl)phenyl-)